Relationships between serum adiponectin and soluble TNF-α receptors and glucose and lipid oxidation in lean and obese subjects

Acta Diabetologica

Volumn 49, Issue 1, 2012, Pages 17-24

  Adamska, A ^a   Nikolajuk A ^a   Karczewska Kupczewska, M ^a   Kowalska, I ^a   Otziomek, E ^a   Gorska M ^a   Straczkowski M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Adiponectin; Obesity; Soluble TNF receptors; Substrate oxidation

Indexed keywords

ADIPONECTIN; SOLUBLE TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; SOLUBLE TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG; ADIPOQ PROTEIN, HUMAN; LIPID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIPID OXIDATION; MALE; METABOLIC FLEXIBILITY; METABOLIC PARAMETERS; NON OXIDATIVE GLUCOSE METABOLISM; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; BLOOD; BODY MASS; BODY WEIGHT; COMPARATIVE STUDY; GLUCOSE BLOOD LEVEL; LIPID METABOLISM; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; SOLUBILITY;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; HUMANS; LIPID METABOLISM; LIPIDS; MALE; OBESITY; OXIDATION-REDUCTION; RECEPTORS, TUMOR NECROSIS FACTOR; SOLUBILITY; THINNESS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84861688686     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-010-0252-y     Document Type: Article

References (42)

1. Fernández-Real J, Ricart W (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24:278-301 (Pubitemid 36724371)
2. Meshkani R, Zargari M, Larijani B (2010) The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects. Acta Diabetol (online first)
3. Chokkalingam K, Jewell K, Norton L et al (2007) High-fat/low-carbohydrate diet reduces insulin-stimulated carbohydrate oxidation but stimulates nonoxidative glucose disposal in humans: an important role for skeletal muscle pyruvate dehydrogenase kinase 4. J Clin Endocrinol Metab 92:284-292 (Pubitemid 46067545)
4. Koska J, Ortega E, Bogardus C, Krakoff J, Bunt J (2007) The effect of insulin on net lipid oxidation predicts worsening of insulin resistance and development of type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 293:E264-E269 (Pubitemid 47108170)
5. Salmenniemi U, Ruotsalainen E, Pihlajamäki J et al (2004) Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 110:3842-3848 (Pubitemid 40023983)
6. Golay A, DeFronzo R, Ferrannini E et al (1998) Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31:585-591
7. Haugaard S, Andersen O, Madsbad S et al (2005) Skeletal muscle insulin signaling defects downstream of phosphatidylinositol 3-kinase at the level of Akt are associated with impaired nonoxidative glucose disposal in HIV lipodystrophy. Diabetes 54:3474-3483 (Pubitemid 43334338)
8. Yokoyama H, Emoto M, Mori K et al (2006) Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal. J Clin Endocrinol Metab 91:290-294 (Pubitemid 43069151)
9. de Alvaro C, Teruel T, Hernandez R, Lorenzo M (2004) Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem 279:17070-17078 (Pubitemid 38560462)
10. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323-329
11. Kowalska I, Straczkowski M, Nikołajuk A, Krukowska A, Kinalska I, Górska M (2006) Plasma adiponectin concentration and tumor necrosis factor-alpha system activity in lean non-diabetic offspring of type 2 diabetic subjects. Eur J Endocrinol 154:319-324
12. Straczkowski M, Kowalska I, Nikolajuk A et al (2006) Plasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects. Cardiovasc Diabetol 5:14
13. Straczkowski M, Kowalska I, Stepien A, Dzienis-Straczkowska S, Szelachowska M, Kinalska I (2002) Increased plasma-soluble tumor necrosis factor-alpha receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes Care 25:1824-1828 (Pubitemid 41071094)
14. Hotamisligil G, Budavari A, Murray D, Spiegelman B (1994) Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 94:1543-1549
15. Baratta R, Amato S, Degano C et al (2004) Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab 89:2665-2671 (Pubitemid 38766347)
16. Arita Y, Kihara S, Ouchi N et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83 (Pubitemid 29299050)
17. Hotta K, Funahashi T, Arita Y et al (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595-1599 (Pubitemid 30353893)
18. Hara K, Boutin P, Mori Y et al (2002) Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51:536-540 (Pubitemid 34764814)
19. King G, Deemer S, Thompson D (2010) Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women. Acta Diabetol (online first)
20. Su SC, Pei D, Hsieh C, Hsiao F, Wu C, Hung Y (2010) Circulating pro-inflammatory cytokines and adiponectin in young men with type 2 diabetes. Acta Diabetol (online first)
21. Højlund K, Frystyk J, Levin K, Flyvbjerg A, Wojtaszewski J, Beck-Nielsen H (2006) Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes. Diabetologia 49:1283-1291
22. Storgaard H, Poulsen P, Ling C, Groop L, Vaag A (2007) Relationships of plasma adiponectin level and adiponectin receptors 1 and 2 gene expression to insulin sensitivity and glucose and fat metabolism in monozygotic and dizygotic twins. J Clin Endocrinol Metab 92:2835-2839 (Pubitemid 47037398)
23. Yamauchi T, Kamon J, Minokoshi Y et al (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295 (Pubitemid 35373562)
24. Salmenniemi U, Zacharova J, Ruotsalainen E et al (2005) Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure, and cytokines in offspring of type 2 diabetic patients. J Clin Endocrinol Metab 90:4216-4223 (Pubitemid 41058200)
25. Ceddia R, Somwar R, Maida A, Fang X, Bikopoulos G, Sweeney G (2005) Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia 48:132-139 (Pubitemid 40174665)
26. Hulstrøm V, Højlund K, Vinten J, Beck-Nielsen H, Levin K (2008) Adiponectin and its response to thiazolidinediones are associated with insulin-mediated glucose metabolism in type 2 diabetic patients and their first-degree relatives. Diabetes Obes Metab 10:1019-1028
27. Yin C, Long Q, Lei T et al (2009) Lipid accumulation mediated by adiponectin in C2C12 myogenesis. BMB Rep 42:667-672
28. Sparks L, Ukropcova B, Smith J et al (2009) Relation of adipose tissue to metabolic flexibility. Diabetes Res Clin Pract 83:32-43
29. Peraldi P, Hotamisligil G, Buurman W, White M, Spiegelman B (1996) Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271:13018-13022
30. Cho S, Park P, Shin E, Lee J, Chang H, Lee T (2009) Proteomic analysis of mitochondrial proteins of basal and lipolytically (isoproterenol and TNF-alpha)-stimulated adipocytes. J Cell Biochem 106:257-266
31. Pellieux C, Montessuit C, Papageorgiou I, Lerch R (2009) Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factoralpha. Cardiovasc Res 82:341-350
32. Pamir N, McMillen T, Kaiyala K, Schwartz M, LeBoeuf R (2009) Receptors for tumor necrosis factor-alpha play a protective role against obesity and alter adipose tissue macrophage status. Endocrinology 150:4124-4134
33. Plomgaard P, Fischer C, Ibfelt T, Pedersen B, van Hall G (2008) Tumor necrosis factor-alpha modulates human in vivo lipolysis. J Clin Endocrinol Metab 93:543-549 (Pubitemid 351240829)
34. Palomer X, Alvarez-Guardia D, Rodríguez-Calvo R et al (2009) TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. Cardiovasc Res 81:703-712
35. DeFronzo R, Tobin J, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223 (Pubitemid 9249478)
36. Brun JF et al. (2010) Assessment of insulin sensitivity (SI) and glucose effectiveness (SG) from a standardized hyperglucidic breakfast test in type 2 diabetics exhibiting various levels of insulin resistance. Acta Diabetol (online first)
37. Ruan W et al (2010) Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome? Diabetol 47:5-14
38. Dzienis-Straczkowska S, Straczkowski M, Szelachowska M, Stepien A, Kowalska I, Kinalska I (2003) Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance. Diabetes Care 26:875-880 (Pubitemid 36929358)
39. Ouchi N, Kihara S, Arita Y et al (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102: 1296-1301
40. Yamauchi T, Kamon J, Waki H et al (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946 (Pubitemid 32756432)
41. Hotamisligil G, Peraldi P, Budavari A, Ellis R, White M, Spiegelman B (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665-668 (Pubitemid 26052915)
42. Bruce C, Dyck D (2004) Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab 287:E616-E621 (Pubitemid 39237888)